论文部分内容阅读
目的观察倍他乐克在治疗老年充血性心力衰竭中的临床疗效。方法选择我科2007年6月-2009年6月期间老年充血性心力衰竭患者184例,随机分为对照组和治疗组。对照组应用常规强心、利尿、扩血管药物治疗,治疗组在应用常规强心、利尿、扩血管药物治疗的基础上加用倍他乐克12.5mg,2次/d,1周后改为25mg,2次/d治疗,两组对照比较治疗前后静息心率、心功能分级等临床指标变化,评估倍他乐克的临床疗效和安全性。结果治疗组在改善静息心率及心功能上较对照组明显。结论倍他乐克可显著改善患者心功能,提高患者生存质量。
Objective To observe the clinical efficacy of metoprolol in the treatment of senile congestive heart failure. Methods 184 patients with congestive heart failure in our department from June 2007 to June 2009 were randomly divided into control group and treatment group. The patients in the control group were treated with conventional cardiotonic, diuretic and vasodilator drugs. The patients in the treatment group were given Betaloc to 12.5 mg twice daily after routine cardiac, diuretic and vasodilator drug treatment, and then changed to 25mg, 2 times / d treatment, the two groups compared before and after treatment, resting heart rate, heart function classification and other clinical indicators to assess the clinical efficacy and safety Betaloc. Results The treatment group was better than the control group in improving resting heart rate and heart function. Conclusion Betaloc can significantly improve the cardiac function and improve the quality of life of patients.